Multiple Sclerosis News

Spandex was the attire of choice Saturday when a large pack of bicyclists rode out together to get in shape for the National Multiple Sclerosis Society Eastern N.C. Chapter's bike ride in September.

Framingham-based GTC Biotherapeutics Inc. now has the rights to develop and commercialize a protein that could be used to treat multiple sclerosis and other autoimmune diseases.

Pharmaceutical firm Biogen Idec announced that the American drug watchdog the Food and Drug Administration has granted Fast Track designation for its multiple sclerosis drug PEGylated interferon beta-1a . The company is currently enrolling patients in a global Phase III study evaluating the effectiveness and safety of either bi-weekly or ...

MULTIPLE sclerosis sufferer William McIntyre allegedly conned 19 people out of a total of more than A 700,000, a jury at Truro Crown Court has been told.

A multiple sclerosis drug being developed by Biogen Idec has won Fast Track designation from the U.S. Food and Drug Administration opening the door for a quicker trip through the approval process.

GTC Biotherapeutics, Inc. has obtained exclusive worldwide rights to the development and commercialization of recombinant human alpha-fetoprotein , including the recombinant, non-glycosylated version of rhAFP known as MM-093, for the treatment of autoimmune diseases from Merrimack Pharmaceuticals.

Kineta, Inc. of Seattle and Airmid Incorporated of Redwood City, CA jointly announce an agreement in which a Kineta subsidiary has acquired exclusive commercial rights to a portfolio of novel therapeutic compounds from Airmid.

Shares of Acorda Therapeutics Inc. fell Wednesday after the company gave Biogen Idec Inc.

In my last post , I provided a list of places that may be able to help you with financial assistance for your MS medications.

New Control System Of The Body Discovered - Important Modulator Of Immune Cell Entry Into The Brain - Perhaps New Target For The Therapy Main Category: Neurology / Neuroscience Also Included In: Multiple Sclerosis ; Immune System / Vaccines Article Date: 29 Jun 2009 - 2:00 PDT Researchers in Berlin, Germany have ameliorated inflammation of the ...

People Submitted by Karen E. Butler on 2009-07-02.   Southington residents Jennifer Castonguay and her daughter Jessica Castonguay at the June 8 reception honoring the 2009 Hayley's Hope & Michaela's Miracle MS Scholarship recipients.

Researchers in Berlin, Germany have ameliorated inflammation of the brain in mice caused by immune cells.

Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S. Acorda to Continue to Develop and Commercialize Fampridine-SR in the U.S. Upfront Payment of $110 Million; Potential Deal Value Over $500 Million Acorda to Host Conference Call at 8:30 a.m. Eastern ...

The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco and University of Cambridge and was published today in the journal Genes and Development.

UCB and Biogen Idec announced today the discontinuation of the Phase II clinical trial of CDP323 for the treatment of relapsing multiple sclerosis .

DEAR ANNIE: I am 49, the eldest of four siblings and have been suffering with multiple sclerosis for years.

David Maclean, Conservative MP for Penrith and the Border for 26 years, is to stand down at the next election.

NEW dalia NEW Abstract In the mid-1990s, the implementation of the immunomodulatory drugs interferon-beta and glatiramer acetate offered the first evidence-based treatment option for multiple sclerosis .

The Biogen Idec sign welcomes visitors to the company's RTP operations. Shares of Biogen Idec sunk Monday after the biotechnology giant confirmed that another patient taking the multiple sclerosis drug Tysabri has been diagnosed with a potentially fatal brain infection called progressive multifocal leukoencephalopathy, or PML.

Researchers in Berlin, Germany have ameliorated inflammation of the brain in mice caused by immune cells.